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Abstract
©  2018  Gusliakova,  Atochina-Vasserman,  Sindeeva,  Sindeev,  Pinyaev,  Pyataev,  Revin,
Sukhorukov, Gorin and Gow. Nano- and microencapsulation has proven to be a useful technique
for  the  construction  of  drug delivery  vehicles  for  use  in  vascular  medicine.  However,  the
possibility of using these techniques within the lung as an inhalation delivery mechanism has
not been previously considered. A critical element of particle delivery to the lung is the degree
of penetrance that can be achieved with respect to the airway tree. In this study we examined
the effectiveness of near infrared (NIR) dye (Cy7) labeled calcium carbonate (vaterite) particles
of 3.15, 1.35, and 0.65 μm diameter in reaching the respiratory portion of the lung. First of all, it
was shown that, interaction vaterite particles and the components of the pulmonary surfactant
occurs a very strong retardation of the recrystallization and dissolution of the particles, which
can subsequently be used to create systems with a prolonging release of bioactive substances
after the particles penetrate the distal sections of the lungs. Submicro- and microparticles,
coated with Cy7 labeled albumin as a model compound, were delivered to mouse lungs via
tracheostomy with subsequent imaging performed 24, 48, and 72 h after delivery by in vivo
fluorescence. 20 min post administration particles of all three sizes were visible in the lung, with
the deepest penetrance observed with 0.65 μm particles. In vivo biodistribution was confirmed
by fluorescence tomography imaging of excised organs post 72 h. Laser scanning confocal
microscopy shows 0.65 μm particles reaching the alveolar space. The delivery of fluorophore to
the blood was assessed using Cy7 labeled 0.65 μm particles. Cy7 labeled 0.65 μm particles
efficiently  delivered  fluorescent  material  to  the  blood  with  a  peak  3  h  after  particle
administration. The pharmacokinetics of NIR fluorescence dye will  be shown. These studies
establish  that  by  using  0.65  μm particles  loaded  with  Cy7  we  can  efficiently  access  the
respiratory portion of the lung, which represents a potentially efficient delivery mechanism for
both the lung and the vasculature.
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